These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 26193886

  • 1. Insulin down-regulates the expression of ubiquitin E3 ligases partially by inhibiting the activity and expression of AMP-activated protein kinase in L6 myotubes.
    Deng HP, Chai JK, Shen CA, Zhang XB, Ma L, Sun TJ, Hu QG, Chi YF, Dong N.
    Biosci Rep; 2015 Jul 20; 35(4):. PubMed ID: 26193886
    [Abstract] [Full Text] [Related]

  • 2. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF, Yan X, Zhu MJ, Du M.
    J Cell Biochem; 2009 Oct 01; 108(2):458-68. PubMed ID: 19639604
    [Abstract] [Full Text] [Related]

  • 3. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
    Krawiec BJ, Nystrom GJ, Frost RA, Jefferson LS, Lang CH.
    Am J Physiol Endocrinol Metab; 2007 Jun 01; 292(6):E1555-67. PubMed ID: 17264220
    [Abstract] [Full Text] [Related]

  • 4. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes.
    Nakashima K, Yakabe Y.
    Biosci Biotechnol Biochem; 2007 Jul 01; 71(7):1650-6. PubMed ID: 17617726
    [Abstract] [Full Text] [Related]

  • 5. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.
    Sanchez AM, Csibi A, Raibon A, Cornille K, Gay S, Bernardi H, Candau R.
    J Cell Biochem; 2012 Feb 01; 113(2):695-710. PubMed ID: 22006269
    [Abstract] [Full Text] [Related]

  • 6. 1α,25(OH)2D3 downregulates gene expression levels of muscle ubiquitin ligases MAFbx and MuRF1 in human myotubes.
    Hayakawa N, Fukumura J, Yasuno H, Fujimoto-Ouchi K, Kitamura H.
    Biomed Res; 2015 Feb 01; 36(2):71-80. PubMed ID: 25876656
    [Abstract] [Full Text] [Related]

  • 7. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
    Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL.
    Am J Physiol Endocrinol Metab; 2004 Oct 01; 287(4):E591-601. PubMed ID: 15100091
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. AMP-activated protein kinase regulates E3 ligases in rodent heart.
    Baskin KK, Taegtmeyer H.
    Circ Res; 2011 Oct 28; 109(10):1153-61. PubMed ID: 21921267
    [Abstract] [Full Text] [Related]

  • 10. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E, Alamdari N, Lecker SH, Hasselgren PO.
    Metabolism; 2013 Oct 28; 62(10):1495-502. PubMed ID: 23866982
    [Abstract] [Full Text] [Related]

  • 11. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
    Chen B, Wu Q, Xiong Z, Ma Y, Yu S, Chen D, Huang S, Dong Y.
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep 28; 48(9):827-32. PubMed ID: 27521792
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
    Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ.
    Am J Physiol Cell Physiol; 2009 Jun 28; 296(6):C1258-70. PubMed ID: 19357233
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-1 stimulates catabolism in C2C12 myotubes.
    Li W, Moylan JS, Chambers MA, Smith J, Reid MB.
    Am J Physiol Cell Physiol; 2009 Sep 28; 297(3):C706-14. PubMed ID: 19625606
    [Abstract] [Full Text] [Related]

  • 15. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes.
    Seok YM, Yoo JM, Nam Y, Kim J, Kim JS, Son JH, Kim HJ.
    J Ethnopharmacol; 2021 Apr 24; 270():113557. PubMed ID: 33161026
    [Abstract] [Full Text] [Related]

  • 16. Pyropia yezoensis peptide PYP1‑5 protects against dexamethasone‑induced muscle atrophy through the downregulation of atrogin1/MAFbx and MuRF1 in mouse C2C12 myotubes.
    Lee MK, Kim YM, Kim IH, Choi YH, Nam TJ.
    Mol Med Rep; 2017 Jun 24; 15(6):3507-3514. PubMed ID: 28393223
    [Abstract] [Full Text] [Related]

  • 17. AMP-activated protein kinase stabilizes FOXO3 in primary myotubes.
    Sanchez AMJ, Candau R, Bernardi H.
    Biochem Biophys Res Commun; 2018 May 15; 499(3):493-498. PubMed ID: 29580989
    [Abstract] [Full Text] [Related]

  • 18. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle.
    Edström E, Altun M, Hägglund M, Ulfhake B.
    J Gerontol A Biol Sci Med Sci; 2006 Jul 15; 61(7):663-74. PubMed ID: 16870627
    [Abstract] [Full Text] [Related]

  • 19. Activation of AMP-activated protein kinase stimulates Na+,K+-ATPase activity in skeletal muscle cells.
    Benziane B, Björnholm M, Pirkmajer S, Austin RL, Kotova O, Viollet B, Zierath JR, Chibalin AV.
    J Biol Chem; 2012 Jul 06; 287(28):23451-63. PubMed ID: 22610379
    [Abstract] [Full Text] [Related]

  • 20. Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes.
    Eo H, Reed CH, Valentine RJ.
    Biomed Pharmacother; 2020 Aug 06; 128():110238. PubMed ID: 32450522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.